We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Intense Pulsed Light to Treat Rosacea

By HospiMedica staff writers
Posted on 18 Jul 2003
Intense pulsed light (IPL) can treat hyperpigmentation and erythema associated with rosacea. More...
IPL has been cleared for this application by the US Food and Drug Administration (FDA).

Rosacea involves vascular changes and results in a characteristic erythema, or redness, that appears in the skin as a response to many conditions and processes. The most well-known case is melasma, a darkening around the eyes that often affects women during pregnancy. External factors, such as weather and diet, may cause significant flare-ups.

Unlike a laser, IPL is a broad band of light that can utilize many wavelengths of the electromagnetic spectrum. As a result, both pigmented lesions and capillaries absorb the light simultaneously, allowing for the clearance of pigmentation and vascularity. IPL supplies high levels of nonlaser light power in precision-measured pulses, controlled to one ten-thousandth of a second. IPL and IPL devices were developed by Lumenis Ltd. (Yokneam, Israel).

"Now, Lumenis IPL treatments provide a long-term solution to sufferers of this persistent skin condition who have traditionally been treated by special diets or topical creams with limited degrees of success,” said Alon Maor, executive vice president of Lumenis. The company develops and markets laser and IPL devices that can be used in a variety of aesthetic, ophthalmic, surgical, and dental applications.




Related Links:
Lumenis

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.